Our Studies

We are always accepting participants to join a study.

Here are some of the current trials that are open for enrollment at some of our locations.

  • A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to EvaLuate the EffIcacy and Safety of AbeLacimab in High-risk Patients with Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AntiCoagulation

  • Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS)

  • A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome

  • An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV

  • A Phase 2, Randomized, Double-blind, Placebo--controlled, Parallel Group, 3-arm, Multinational, Multicenter, Proof-of-concept Study to Evaluate the Efficacy and Safety of Amlitelimab Monotherapy by Subcutaneous Injection in Adult Participants With Severe Alopecia Areata

  • A Phase 2 Study to Assess the Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Testimonials

  • "I recently participated in a clinical research trial, under her expert tutelage. The consummate professional, was impressively knowledgeable with a relaxing, gracious manner. Savvy and considerate of my needs without forsaking meticulous attention to every detail surrounding her goal to obtain the best outcome of the trial, her attention never wavered. Her explanations were right on point, and she never hesitated to respond to my inquiries with clear, precise responses, always keeping her focus undistracted and fine-tuned. This charismatic young woman with excellent interpersonal skills and an elite clinical savoir-faire is an asset to FWD and the world of clinical research! Thanks, for a rewarding experience.

    - Research Trial Participant, Boca Raton, FL